VIKING GLOBAL INVESTORS LP Insider Trading $BBIO BridgeBio Pharma, Inc.
Get free email notifications about insider trading for VIKING GLOBAL INVESTORS LP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of VIKING GLOBAL INVESTORS LP. VIKING GLOBAL INVESTORS LP is 10% Owner in FIRST DATA CORP ($FDC) and 10% Owner in Arbutus Biopharma Corp ($TKMR) and 10% Owner in Adaptive Biotechnologies Corp ($ADPT) and 10% Owner in Wayfair Inc. ($W) and 10% Owner in Axovant Sciences Ltd. ($AXON) and 10% Owner in 4D Molecular Therapeutics Inc. ($FDMT) and 10% Owner in Editas Medicine, Inc. ($EDIT) and 10% Owner in Myovant Sciences Ltd. ($MYOV) and 10% Owner in Zentalis Pharmaceuticals, Inc. ($ZNTL) and 10% Owner in Inhibrx, Inc. ($INBX) and 10% Owner in BridgeBio Pharma, Inc. ($BBIO) and 10% Owner in Urovant Sciences Ltd. ($UROV).
VIKING GLOBAL INVESTORS LP in BridgeBio Pharma, Inc.
Trading Symbol: BBIOIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of VIKING GLOBAL INVESTORS LP: 10% Owner
Holdings: 11,736,137 shares
Latest Transaction: Jun 28 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of VIKING GLOBAL INVESTORS LP in BridgeBio Pharma, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, FDMT, ADPT, TKMR, BBIO, EDIT, FDC, INBX, MYOV, AXON, UROV, W, ZNTL
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 28 2019 | BBIO | BridgeBio Pharma, ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Option Exercise | C | 0.00 | 50,446,451 | 0 | 0 | |
Jun 28 2019 | BBIO | BridgeBio Pharma, ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Option Exercise | C | 0.00 | 51,781,276 | 0 | 0 | |
Jun 28 2019 | BBIO | BridgeBio Pharma, ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 17.00 | 4,705,900 | 80,000,300 | 26,620,991 | 21.9 M to 26.6 M (+21.47 %) |
Jun 28 2019 | BBIO | BridgeBio Pharma, ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | C | 0.00 | 10,178,954 | 0 | 21,915,091 | 11.7 M to 21.9 M (+86.73 %) |
Jun 28 2019 | BBIO | BridgeBio Pharma, ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | C | 0.00 | 11,736,137 | 0 | 11,736,137 | 0 to 11.7 M |
Page: 1